BioAgilytix Labs & Gyrolab®

  1. Home

  2. caret-right icon

    Immunoassay Solutions

  3. caret-right icon

    About Gyrolab

  4. caret-right icon

    CRO Partners

  5. caret-right icon

    BioAgilytix Labs & Gyrolab

“Gyrolab® removes the expensive, time-consuming roadblocks typically associated with processing low-volume samples by significantly reducing sample and reagent consumption. The platform automates assay workflows yielding rapid, accurate results for timely and effective decision-making.”

 

BioAgilytix

BioAgilytix is an industry leader in immunoassay development and validation. Our team has extensive experience across a wide range of methodologies supporting nonclinical and clinical therapeutic programs.  

Our immunoassay experts provide customers with dependable data throughout assay development, validation, and sample analysis. These scientific teams skillfully navigate even the most complex immunoassay methods to ensure all bioanalytical laboratory services meet expected budgets and timelines.

BioAgilytix Labs & Gyrolab®

BioAgilytix and Gyrolab

BioAgilytix uses the proprietary microfluidics system of the Gyros platform to perform immunoassays. This approach generates quick, reproducible results using smaller sample volumes than traditional techniques. 

BioAgilytix makes Gyrolab our go-to technology for customer immunoassays that require low-volume samples to be processed efficiently on a tight schedule with high precision. Its flow-through affinity column format minimizes matrix interference using nanoliter-sized samples. We are experts in leveraging the Gyros platform’s unique capabilities to maximize precious samples and deliver necessary assays quickly and reliably. 

The BioAgilytix team uses Gyrolab xP and xPand workstations to support our work with  pharmacokinetics (PK), and biomarkers. We can also tailor the platform to meet your unique assay specifications. 

Associate Director of Operations Carla Mejia explains, “Gyrolab removes the expensive, time-consuming roadblocks typically associated with processing low-volume samples by significantly reducing sample and reagent consumption. The platform automates assay workflows yielding rapid, accurate results for timely and effective decision-making.”

About BioAgilytix

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC bioanalytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit  www.bioagilytix.com.